An advance in UVB-based phototherapy has been the introduction of fluoresce
nt lightbulbs (Philips TL-01) that deliver monochromatic light at 311-nm UV
B, a narrowband wavelength that seems to maximize clearing of plaques relat
ive to its erythrogenic potential. Narrowband UVB phototherapy has consider
able advantages over traditional treatment options such as broadband UVB an
d psoralen plus UVA (PUVA). It is clearly more effective than broadband UVB
, safer than PUVA, and well tolerated by patients when taken at suberythemo
genic doses. Narrowband UVB represents an important new therapy for psorias
is.